Literature DB >> 15716547

Genotype-phenotype correlation in a family with late onset CMT and an MPZ lys236del mutation.

J E Sowden1, E L Logigian, K Malik, D N Herrmann.   

Abstract

An in frame, lys236 deletion in the intracytoplasmic domain of myelin protein zero (MPZ) has recently been designated as a mutation possibly associated with Charcot-Marie-Tooth disease (CMT) but requiring further documentation. In this report we present a detailed clinical, electrophysiological, and genotype correlation in three generations of a family with the MPZ lys236del mutation and provide further evidence that this mutation is associated with CMT. The MPZ lys236del mutation is associated with an autosomal dominant, adult onset CMT phenotype, with variable penetrance ranging from an asymptomatic state to foot deformities, pedal numbness, and muscle cramps. Nerve conduction studies disclose intermediate range, somewhat non-uniform slowing of motor nerve conduction, which is accentuated in forelimb rather than distal nerve segments. Based on the contrasting finding of entirely normal conduction velocities (CV) in a genetically affected 15 year old in this family, it remains to be established whether CV slowing with this mutation is progressive in life, a pattern that would contrast with CMT1a (PMP22 gene duplication).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15716547      PMCID: PMC1739547          DOI: 10.1136/jnnp.2004.043968

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  6 in total

Review 1.  Molecular genetics of autosomal-dominant axonal Charcot-Marie-Tooth disease.

Authors:  Stephan Züchner; Jeffery M Vance
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 2.  Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review.

Authors:  José Berciano; Antonio García; Elena Gallardo; Kristien Peeters; Ana L Pelayo-Negro; Silvia Álvarez-Paradelo; José Gazulla; Miriam Martínez-Tames; Jon Infante; Albena Jordanova
Journal:  J Neurol       Date:  2017-03-31       Impact factor: 4.849

3.  Reduced penetrance in hereditary motor neuropathy caused by TRPV4 Arg269Cys mutation.

Authors:  José Berciano; Jonathan Baets; Elena Gallardo; Magdalena Zimoń; Antonio García; Eduardo López-Laso; Onofre Combarros; Jon Infante; Vincent Timmerman; Albena Jordanova; Peter De Jonghe
Journal:  J Neurol       Date:  2011-02-19       Impact factor: 4.849

4.  Myelin protein zero mutation His39Pro: hereditary motor and sensory neuropathy with variable onset, hearing loss, restless legs and multiple sclerosis.

Authors:  D H Kilfoyle; P J Dyck; Y Wu; W J Litchy; D M Klein; P J B Dyck; N Kumar; J M Cunningham; C J Klein
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-08       Impact factor: 10.154

Review 5.  New evidence for secondary axonal degeneration in demyelinating neuropathies.

Authors:  Kathryn R Moss; Taylor S Bopp; Anna E Johnson; Ahmet Höke
Journal:  Neurosci Lett       Date:  2020-12-24       Impact factor: 3.046

6.  Genotype-phenotype characteristics and baseline natural history of heritable neuropathies caused by mutations in the MPZ gene.

Authors:  Oranee Sanmaneechai; Shawna Feely; Steven S Scherer; David N Herrmann; Joshua Burns; Francesco Muntoni; Jun Li; Carly E Siskind; John W Day; Matilde Laura; Charlotte J Sumner; Thomas E Lloyd; Sindhu Ramchandren; Rosemary R Shy; Tiffany Grider; Chelsea Bacon; Richard S Finkel; Sabrina W Yum; Isabella Moroni; Giuseppe Piscosquito; Davide Pareyson; Mary M Reilly; Michael E Shy
Journal:  Brain       Date:  2015-08-25       Impact factor: 13.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.